Zevra Therapeutics (ZVRA) Short term Debt (2020 - 2023)

Zevra Therapeutics has reported Short term Debt for 3 years, with the latest figure at $37.7 million in Q4 2023.

• For the quarter ending Q4 2023, Short term Debt changed N/A year-over-year to $37.7 million; the trailing twelve-month figure through Dec 2023 stood at $37.7 million (changed N/A YoY), and the FY2023 full-year result was $37.7 million, changed N/A from the prior year.
• Short term Debt for Q4 2023 stood at $37.7 million, up from $683000.0 in the prior quarter.
• The five-year high for Short term Debt was $37.7 million in Q4 2023, with the low at $390000.0 in Q4 2020.
• Historically, Short term Debt has averaged $12.9 million across 3 years, with a median of $683000.0 in 2021.